KENNETH SUMNER: Open Payments
NPI 1073653275 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,066 in 165 payments from 16 companies in 2025. Trend: 2023 $2,959 · 2024 $3,225 · 2025 $3,066
Food & beverage: $3,066
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $405 |
| Otsuka America Pharmaceutical, Inc. | 17 | $387 |
| Axsome Therapeutics, Inc. | 14 | $325 |
| Alkermes, Inc. | 11 | $265 |
| Vanda Pharmaceuticals Inc. | 12 | $239 |
| Janssen Pharmaceuticals, Inc | 13 | $233 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $201 |
| Teva Pharmaceuticals USA, Inc. | 17 | $192 |
| Lundbeck LLC | 8 | $160 |
| Almatica Pharma LLC | 7 | $146 |
Products named: REXULTI, VRAYLAR, Auvelity, ARISTADA, FANAPT, SPRAVATO, CAPLYTA, LOREEV XR.
Industry payments across LA — which companies pay providers there.
